VH

Vectis Healthcare & Life Sciences Fund

North America, Missouri, United States, St Louis

Description

Vectis Healthcare & Life Sciences Fund specializes in venture capital and private equity funds and direct co-investments.

Investor Profile

Vectis Healthcare & Life Sciences Fund has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (50%)
  • Series B (33%)
  • Series D (17%)

Country Focus

  • United States (83%)

Industry Focus

  • Medical
  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical Device
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Vectis Healthcare & Life Sciences Fund frequently co-invest with?

Baird Capital
North America, Wisconsin, United States, Milwaukee
Co-Investments: 1
TVM Capital
Europe, Bayern, Germany, Munich
Co-Investments: 3
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 3
Skyline Ventures
North America, California, United States, Palo Alto
Co-Investments: 3
Intersouth Partners
North America, North Carolina, United States, Durham
Co-Investments: 3
Prolog Ventures
North America, Missouri, United States, St Louis
Co-Investments: 2
C
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 1
Devon Park BioVentures
North America, Pennsylvania, United States, Wayne
Co-Investments: 3
Bessemer Venture Partners
North America, California, United States, San Francisco
Co-Investments: 3
Prism Venture Management
North America, Massachusetts, United States, Needham
Co-Investments: 3

What are some of recent deals done by Vectis Healthcare & Life Sciences Fund?

Veniti

Fremont, California, United States

Veniti develops medical devices for the treatment of chronic venous insufficiency disease.

BiotechnologyHealth CareMedicalMedical Device
Series CMar 10, 2015
Amount Raised: $17,000,000
Proteon Therapeutics

Waltham, Massachusetts, United States

Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.

BiotechnologyMedicalPharmaceutical
Series DMay 16, 2014
Amount Raised: $45,000,000
Proteon Therapeutics

Waltham, Massachusetts, United States

Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.

BiotechnologyMedicalPharmaceutical
Series CAug 12, 2011
Amount Raised: $15,200,000
EndoStim

St Louis, Missouri, United States

EndoStim is a medical device company developing therapeutics for gastrointestinal and urological neuro-muscular disorders.

BiotechnologyMedicalMedical DeviceTherapeutics
Series BJul 19, 2010
Amount Raised: $6,000,000
Proteon Therapeutics

Waltham, Massachusetts, United States

Proteon Therapeutics is a biopharmaceutical company developing pharmaceuticals for patients with renal and vascular diseases.

BiotechnologyMedicalPharmaceutical
Series BMay 28, 2009
Amount Raised: $50,000,000

Spherics develops proprietary bioadhesive encapsulation technologies to improve the oral absorption of small molecule drugs.

Health CareMedicalTherapeutics
Series CMay 12, 2005
Amount Raised: $26,400,000